ArticleJournal of inflammation research2025
Causal Association Between Genetically Predicted Circulating Metabolites and Pressure Ulcers: A Two-Sample Mendelian Randomization Study.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Pressure ulcers (PU) are skin and soft tissue injuries caused by prolonged localized pressure, friction, or shear forces, particularly affecting individuals with limited mobility. Understanding the mechanisms behind PU formation, including the role of metabolites, is crucial for effective prevention. Methods: We conducted a two-sample MR analysis to explore the causal relationship between circulating metabolites and PU. Exposure data included GWAS data for 1400 metabolites, while outcome data were sourced from a Finnish database. We used multiple MR methods (IVW, MR-Egger, WM, Simple mode, Weighted mode) to estimate causal effects and performed sensitivity analyses to assess robustness. Additionally, we validated the effects of key metabolites on PU through animal experiments. Results: A total of 19 metabolites demonstrated significant causal associations with PU (P < 0.01). Among them, 7 metabolites were linked to PU increased risk, the highest ORs was (IVW: OR [95% CI] = 1.3690 [1.0852-1.7270]; P = 0.0080) for the spermidine to choline ratio. 12 metabolites with positive effects on PU prevention, the homostachydrine levels showing a highest association (IVW: OR [95% CI] = 0.7497 [0.6206-0.9056]; P = 0.0028). Sensitivity analyses supported these findings and validated the stability of the results. In animal experiments, rats treated with HD-Hom and LR (Spe/Cho) showed the fastest scab shedding and new epithelial tissue formation, with the smallest residual wound area. Conclusion: This study highlights significant causal relationships between circulating metabolites and PU risk. The identification of the spermidine to choline ratio as a risk factor and homostachydrine levels as a protective factor suggests potential metabolic targets for PU prevention and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.